Success Story
Turning R&D costs into funding: Agfa-Gevaert HealthCare’s research allowance success with innoscripta
Aligned internal cost records
Process clarity through expertise
Industry
Medical Technology
Company Size
Large Enterprise
Location
Düsseldorf, Germany
“Key success factors in our collaboration with innoscripta were the personalized consulting and the structured, clear guidance throughout the process. The conversion of our internal cost records into the government-mandated structures using innoscripta's software platform was also extremely helpful.”
Meet the Agfa-Gevaert HealthCare GmbH
Agfa-Gevaert HealthCare is a company deeply dedicated to supporting healthcare professionals worldwide with secure, effective, and sustainable imaging data management. Agfa-Gevaert HealthCare is a division of the Agfa-Gevaert Group headquartered in Mortsel, Belgium. Their vision is to share a world where Enterprise Imaging becomes a catalyst for remarkable patient care, and their mission aims at delivering imaging without challenges and strengthening individuals to reach their utmost potential. Agfa-Gevaert HealthCare's customer delivery principles that include trust, reliability, integrity, curiosity, and harmony direct how the company develops relationships, drives innovation, and creates technology experiences that are seamless and intuitive.
As a renowned empowerer of the healthcare community and one of the pioneers in bringing Enterprise Imaging to market, Agfa-Gevaert HealthCare offers a unified and evolving Enterprise Imaging Platform. Designed to generate connected, collaborative, and scalable ecosystems, it enables rapid access, real-time collaboration, and a comprehensive patient view, supporting care teams to improve patient experiences.
From uncertainty to successful research funding
The Challenge
With Agfa-Gevaert HealthCare's promising R&D work, the government-backed research allowance programme was a strong opportunity to leverage the expenditures incurred and refinance them into further research funding.
The hurdle they had to overcome in pursuing this funding opportunity arose from a lack of internal resources that could deal with research funding issues. Limited time and ambiguity around the eligibility criteria and programme structure pushed them to the initial assumption that the process to achieve this R&D financial support was bureaucratic, time-consuming and that it might generate a minimal economic value.
The Solution
Collaboration with innoscripta opened effective ways for Agfa-Gevaert HealthCare to tackle the challenges in the process of research allowance.
Personal and customised guidance from innoscripta throughout the process generated a smooth structure. innoscripta's Clusterix platform supported the translation of internal cost documentation of R&D projects into the required government-compliant format, making the application process significantly more manageable and transparent.
The Impact
With innoscripta's support, Agfa-Gevaert HealthCare was able to submit research allowance claims for multiple projects successfully.
The positive outcomes also include the retroactive funding for completed projects, which enabled the refinancing of innovation costs. The swift process, which was easier than the company's anticipation, reinforced the confidence in research funding as a valuable opportunity.
“If you are still skeptical about research funding, talk to innoscripta!”
